Verastem VSTM Earnings Call Transcripts

NASDAQ VSTM
$9.09 +0.36 (+4.12%)
At close: Nov 11, 2026 · 4:00 PM EST
4 earnings calls on file for Verastem, from Q4 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Verastem Q3 2026 Earnings Call

Nov 5, 2026 7,916 words · 34 min read
  • Julissa VianaSenior Vice President of Corporate Communications, Investor Relations and Patient Advocacy
  • Daniel PatersonPresident and Chief Executive Officer
  • Dan LyonsChief Commercial Officer
  • Dr. Michael D. KauffmanPresident of Development
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Verastem Earnings Call Transcripts

Calls4
LatestNov 5, 2026
SinceQ4 2025

Fiscal 2026

Fiscal 2025

All 4 Verastem transcripts Register to get access to Verastem’s earnings call transcripts.